Skip to main content
Signal8

KEATING LAURIE

SEC insider (Form 3/4/5 filer). CIK 0001620743. Director at Kalaris Therapeutics, Inc. (KLRS) and 2 other issuers. 7 reported Form 4/5 transactions since Sep 2024; latest on Aug 1, 2026. Located in BERKELEY HEIGHTS, NJ.

Companies KEATING LAURIE has filed insider reports for

  • Kalaris Therapeutics, Inc. (KLRS): Director
  • PepGen Inc. (PEPG): Director
  • Immuneering Corp (IMRX): Director
KEATING LAURIE profile photo

KEATING LAURIE

CIK: 0001620743

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)7 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

Kalaris Therapeutics, Inc. logo
KLRS

Kalaris Therapeutics, Inc.

Director
PepGen Inc. logo
PEPG

PepGen Inc.

Director
Immuneering Corp logo
IMRX

Immuneering Corp

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • Kalaris Therapeutics, Inc. logo
    KLRS

    Kalaris Therapeutics, Inc.

    Aug 1, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    18K shares-
  • PepGen Inc. logo
    PEPG

    PepGen Inc.

    Jun 18, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    34K shares-
  • Immuneering Corp logo
    IMRX

    Immuneering Corp

    Jun 11, 2026
    Award

    Stock Option

    Direct
    33.4K shares-
  • Immuneering Corp logo
    IMRX

    Immuneering Corp

    Jan 1, 2026
    Award

    Stock Option

    Direct
    7.9K shares-
  • Immuneering Corp logo
    IMRX

    Immuneering Corp

    Jun 13, 2025
    Award

    Stock Option

    Direct
    33.4K shares-
  • PepGen Inc. logo
    PEPG

    PepGen Inc.

    Jun 4, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    16K shares-
  • Immuneering Corp logo
    IMRX

    Immuneering Corp

    Jan 1, 2025
    Award

    Stock Option

    Direct
    23.5K shares-

1-7 of 7